Pressroom

The campaign could have saved about 670,000 more lives had the vaccines been distributed equitably, according to a working paper from the USC Schaeffer Center and Brown University.

Children infected with the Omicron variant remained infectious for a median time of three days after testing positive for the virus, according to USC Schaeffer Center and Stanford researchers.

Researchers study the health and economics issues associated with cognitive decline and dementia, and particularly the inequitable burden of Alzheimer’s.

A new study from the USC Schaeffer Center and Harvard University is the first to examine the “revolving door” in health care.

Medicare released the list of the first 10 drugs subject to price negotiations under the Inflation Reduction Act (IRA), aiming to reduce drug costs for Medicare enrollees and taxpayers.

‘Forgotten middle’ Americans face poorer health, worse economic outcomes and lower homeownership rates, along with increased disability in old age.

USC Schaeffer Center research finds intensive lifestyle intervention for people with type 2 diabetes – including weekly counseling on diet and exercise – is associated with increased employment. Researchers say the results suggest the potential of better chronic disease management for improving long-term labor market outcomes.

USC research finds that the answer to getting more shots into arms is just a text message or email away.

Published in JAMA, the findings from USC and University of Wisconsin–Madison researchers suggest the policy cut the number of Medicare enrollees who weren’t filling insulin because of cost.

For the first time in two decades, an Alzheimer’s drug has received full Food and Drug Administration (FDA) approval. USC Schaeffer Center experts are available to discuss this milestone and the challenges ahead.